Birmingham, West Midlands -- (SBWIRE) -- 12/03/2013 -- Value Penny Stocks issues special report on Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Alpha Natural Resources, Inc. (NYSE:ANR), Galena Biopharma Inc (NASDAQ:GALE), DryShips Inc. (NASDAQ:DRYS).
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) ended its recent business day with the gain of 1.86% and closed at the price of $4.93 after opening at $5.02. The stock traded during its last trading session with the total volume of 34.67 million shares, as compared to its average volume of 23.58 million shares. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
For How Long ARIA will Fight for Profitability? Read This Trend Analysis report
Alpha Natural Resources, Inc. (NYSE:ANR) remained among the day advancers and traded with volume of 12.30 million shares in the last session, as compared to average volume of 13.11 million shares. In comparison with 52 week range of $4.78 - $10.74, it faced lowest price of $6.57 during the last trading session whereas its day highest price was $6.94. The company’s total market capitalization is $1.50 billion, along with 220.96 million shares outstanding. Alpha Natural Resources, Inc., together with its subsidiaries, engages in extracting, processing, and marketing steam and metallurgical coal in Virginia, West Virginia, Kentucky, Pennsylvania, and Wyoming.
For How Long ANR’s Gloss will Attract Investors? Find out via this report
Galena Biopharma Inc (NASDAQ:GALE) showed 12.13 million shares in volume during the last trading session, while the average trading volume remained 4.24 million shares. The stock kicked off its trading session at $4.05 and closed at $4.49 after mounting 12.25%. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Will GALE Continue To Move Higher? Find Out Here
DryShips Inc. (NASDAQ:DRYS) stock traded during its last trading session with the total traded volume of 10.50 million shares versus its average volume of 12.01 million shares. The company opened its trade at the price of $3.49 and its closing price was $3.33 after losing -3.20% for the day. DryShips Inc. owns drybulk carriers and tankers that operate worldwide. The company, through its majority owned subsidiary, Ocean Rig, owns and operates 10 offshore ultra deepwater drilling units.
Will DRYS Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)